JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumors|ER+ Breast Cancer|Triple Negative Breast Cancer, TNBC|ARID1A Gene Mutation|Small Cell Lung Cancer, SCLC
Interventions: DRUG: JAB-2485 (Aurora A inhibitor)|DRUG: JAB-2485 (Aurora A inhibitor)
Sponsor: Jacobio Pharmaceuticals Co., Ltd.